In prostate cancers, EZH2 has dual functions in that it acts as a transcriptional activator mediated by the induction of AR-regulated genes and as a gene silencer mediated by the epigenetic modification suppression of AR-regulated genes [145]. This evidence concerns the gene AR and Familial prostate cancer.